Clarivate is a global provider of research intelligence and data-driven insights, operating across academia, government, life sciences, healthcare, and intellectual property sectors. The company's core offering - what it calls "transformative intelligence" - combines enriched data, analytics, and workflow solutions delivered by a distributed team of researchers, data scientists, and industry experts. While Clarivate positions itself primarily as an innovation accelerator for scientific research and IP management, the scale and sensitivity of the data it handles creates a significant attack surface that would require sophisticated security infrastructure.
The technical operation spans multiple domains: research data management, analytics platforms, and intelligence delivery systems serving academic institutions, life sciences companies developing treatments, and organizations managing intellectual property portfolios. The company's global footprint and customer promise to "deliver insights customers can trust" suggests a security posture built around data integrity, confidentiality, and availability - particularly critical given the proprietary research and IP data flowing through its systems. The workforce composition indicates distributed operations requiring secure collaboration infrastructure across international boundaries.
From a threat modeling perspective, Clarivate sits at the intersection of high-value research data, pharmaceutical development intelligence, and patent information - all targets for both commercial espionage and nation-state actors. The company emphasizes integrity and accountability as organizational values, which in practice would translate to security controls around data provenance, access management, and audit trails. Led by CEO Matti Shem Tov and headquartered in the UK, the company operates infrastructure supporting researchers advancing scientific discovery and companies developing treatments, making the security of its platforms material to broader innovation ecosystems.
